SAM
ATRS

Sectoral Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Sectoral Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-47,280
Closed -$156K – 90
2019
Q2 		$156K Hold
47,280
– – 0.02% 79
2019
Q1 		$143K Hold
47,280
– – 0.02% 94
2018
Q4 		$129K Hold
47,280
– – 0.02% 90
2018
Q3 		$159K Buy
+47,280
New +$146K 0.02% 146

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

Sectoral Asset Management's ATRS Position: Q3 2019 in Review

Sectoral Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q3 2019, closing a stake of 47,280 shares — an estimated $156K sold.

Sectoral Asset Management first reported a position in ATRS in Q3 2018 and held it in 4 quarters. The position peaked at $159K in Q3 2018. 135 funds tracked by Wall St. Rank hold ATRS as of Q3 2019.

  • Sectoral Asset Management reported no remaining Antares Pharma, Inc. position as of Q3 2019 after selling out during the quarter.
  • Sectoral Asset Management sold 47,280 Antares Pharma, Inc. shares in Q3 2019, an estimated $156K.
  • Sectoral Asset Management first reported a position in Antares Pharma, Inc. in Q3 2018 and held it in 4 quarters.
  • Sectoral Asset Management's Antares Pharma, Inc. position peaked at $159K in Q3 2018.
  • 135 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2019.

Based on Sectoral Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.